FKBP7 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87442
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human FKBP7. Peptide sequence: FTAQRQKKEESTEEVKIEVLHRPENCSKTSKKGDLLNAHYDGYLAKDGSK The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for FKBP7 Antibody - BSA Free
![Western Blot: FKBP7 Antibody [NBP2-87442]](https://resources.bio-techne.com/images/products/FKBP7-Antibody-Western-Blot-NBP2-87442-img0001.jpg "Western Blot: FKBP7 Antibody [NBP2-87442]")
Western Blot: FKBP7 Antibody [NBP2-87442]
Western Blot: FKBP7 Antibody [NBP2-87442] - Host: Rabbit. Target Name: FKBP7. Sample Tissue: Human Shoulder Nerve Fiber Tumor lysates. Antibody Dilution: 1ug/mlApplications for FKBP7 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FKBP7
Alternate Names
EC 5.2.1.8, FK506 binding protein 7, FK506-binding protein 7FK506-binding protein 23,23 kDa FK506-binding protein, FKBP-23, FKBP23PPIase, FKBP-7, MGC9420, peptidyl-prolyl cis-trans isomerase FKBP7,23 kDa FKBP, PPIase FKBP7, rotamase
Gene Symbol
FKBP7
Additional FKBP7 Products
Product Specific Notices for FKBP7 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...